Shuo Ma, MD, PhD
Northwestern University
3
3
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+4 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Agostino Tafuri
AOU Sant'Andrea
Shared therapeutic areas:
Laura Nocilli
Ospedale Papardo
Shared therapeutic areas:
Vincenzo Fraticelli
Responsible Research Hospital
Shared therapeutic areas:
Roberta Murru
Ospedale Oncologico" A. Businco" - ARNAS "G. Brotzu"
Shared therapeutic areas:
Jae Park, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Worked with same sponsors:
Luca Laurenti
Policlinico Universitario Gemelli IRCCS
Shared therapeutic areas:
Hagop Youssoufian, MD
Verastem, Inc.
Shared therapeutic areas:
Caterina Cecilia Stelitano
Grande Ospedale Metropolitano Bianchi-Melacrino-Morelli
Shared therapeutic areas:
Pellegrino Musto
AOU Policlinico Consorziale di Bari
Shared therapeutic areas:
Gaetano De Santis
Ospedale "Mon. Dimiccoli" Barletta
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia
Vaccine Therapy for Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL)
Venetoclax, Rituximab and Nivolumab in Combination for the Treatment of Richter's Transformation Arising From Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
All 3 trials loaded